SEBI adjudicates Bhavin Thakkar over Evexia Lifecare trades
A suspicious transaction report and BSE probe led SEBI to act against Bhavin Sureshbhai Thakkar for alleged fraudulent trading in Evexia Lifecare in 2016. No penalty has been set yet.
What changed
- SEBI initiated adjudication against Thakkar for violating PFUTP regulations during Aug-Nov 2016.
- Case stems from FIU-IND suspicious transaction report and BSE investigation into unusual trading.
- Penalty amount not yet disclosed.
The read
SEBI's latest adjudication targets one individual. The case began with an FIU-IND alert on concentrated trading by another entity, then a BSE probe, and finally SEBI's own look at Thakkar's trades in Evexia Lifecare from August to November 2016. No penalty has been imposed yet—the order only establishes the proceedings. That makes this a procedural step rather than a verdict. But the pattern is worth watching: SEBI is still chasing eight-year-old trades, using cross-references from suspicious transaction reports. For market participants, the message is clear: the surveillance tail is long.
Primary source: official circular (PDF)